Dare Bioscience Inc. (DARE)
Symbol Info
Listed Symbol DARE
Name Dare Bioscience Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $-
Latest Fiscal EPS $-1.68
Price Info
21 Day Moving Average $0.7781
21 Day EMA $0.779840
50 Day Moving Average $0.7927
50 Day EMA $0.792680
200 Day EMA $0.905120
200 Day Moving Average 0.908180
52 Week High $3.25
52 Week Low $0.60
52 Week Change $-17.582900
Alpha -0.050524
Beta 1.8802
Standard Deviation 0.237998
R2 0.073605
Periods 60
Share Information
10 Day Average Volume 55,532
20 Day Average Volume 54,410
30 Day Average Volume 62,172
50 Day Average Volume 80,187
Outstanding Shares 16,683,411
Float Shares 16,138,256
Percent Float 96.73%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 31
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 125,811
Institute Holdings Percent 6.200000
Institute Sold Previous 3 Months 105,472
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 6
Insider Holdings Percent 3.30%
Insider Sold Previous 3 Months -
Insiders Shares Owned 545,155
Price Change
7 Day Price Change $0.0859000
7 Day Percent Change 11.89%
21 Day Price Change $0.0281000
21 Day Percent Change 3.60%
30 Day Price Change $-0.0375
30 Day Percent Change -4.43%
Month To Date Price Change $0.0281
Month To Date Percent 3.60%
90 Day Price Change $0.008100
90 Day Percent Change 1.01%
Quarter To Date $0.028100
Quarter To Date Percent 3.60%
180 Day Price Change $-0.2019
180 Day Percent Change -19.99%
200 Day Price Change $-0.6219
200 Day Percent Change -43.49%
Year To Date $0.097600
Year To Date Percent 13.74%
Profile
Description Dare Bioscience Inc is a clinical-stage biopharmaceutical company focused on women's reproductive health. The products of the company are related to fertility, vaginal health, and contraception. Ovaprene is a product designed by the company to provide multiple weeks of contraceptive protection without the use of hormones.
Details
Issue Type CS
Market Cap $13,481,864
Sec Type EQS
Auditor Mayer Hoffman McCann P.C.
Total Shares Outstanding 16,683,411
CEO Sabrina Martucci Johnson
Employees 14
Last Audit UE
Classification
CIK 0001401914
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 3655 Nobel Drive
Suite 260
San Diego, CA 92122
Website https://www.darebioscience.com
Facisimile
Telephone +1 858 926-7655
Email ir@ceruleanrx.com
Key Ratios
Profitability
EBIT Margin -
EBITDA Margin -
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $-
Revenue Per Share $-
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $7,382,491
Price To Sales -
Price To Free Cash -1.4
PE High Last 5 Years -
Price To Book 2.5
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 2.5
Financial Strength
Total Debt To Equity -
Int Coverage -
Current Ratio 3.3
Leverage Ratio 1.6
Quick Ratio 3.1
Long Term Debt To Capital -
Assets
Receivables Turnover -
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets -128.08
Return On Equity -153.57
Return On Capital -153.57
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type
Your Recent History
NASDAQ
DARE
Dare Biosc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20191021 20:28:31